Steven Rowe

Assistant Professor

20032020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Steven Rowe is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

18F-labeled, PSMA-targeted radiotracers: Leveraging the advantages of radiofluorination for prostate cancer molecular imaging

Werner, R. A., Derlin, T., Lapa, C., Sheikbahaei, S., Higuchi, T., Giesel, F. L., Behr, S., Drzezga, A., Kimura, H., Buck, A. K., Bengel, F. M., Pomper, M. G., Gorin, M. A. & Rowe, S. P., 2020, In : Theranostics. 10, 1, p. 1-16 16 p.

Research output: Contribution to journalReview article

Open Access
  • A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)

    Hasan, H., Deek, M. P., Phillips, R., Hobbs, R. F., Malek, R., Radwan, N., Kiess, A. P., Dipasquale, S., Huang, J., Caldwell, T., Leitzel, J., Wendler, D., Wang, H., Thompson, E., Powell, J., Dudley, S., Deville, C., Greco, S. C., Song, D. Y., Deweese, T. L. & 11 others, Gorin, M. A., Rowe, S. P., Denmeade, S., Markowski, M., Antonarakis, E. S., Carducci, M. A., Eisenberger, M. A., Pomper, M. G., Pienta, K. J., Paller, C. J. & Tran, P. T., Jun 1 2020, In : BMC cancer. 20, 1, 492.

    Research output: Contribution to journalArticle

    Open Access
  • A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer

    Ross, A. E., Hurley, P. J., Tran, P. T., Rowe, S. P., Benzon, B., Neal, T. O., Chapman, C., Harb, R., Milman, Y., Trock, B. J., Drake, C. G. & Antonarakis, E. S., Mar 1 2020, In : Prostate Cancer and Prostatic Diseases. 23, 1, p. 184-193 10 p.

    Research output: Contribution to journalArticle

  • Appropriate use criteria for imaging evaluation of biochemical recurrence of prostate cancer after definitive primary treatment

    Jadvar, H., Ballas, L. K., Choyke, P. L., Fanti, S., Gulley, J. L., Herrmann, K., Hope, T. A., Klitzke, A. K., Oldan, J. D., Pomper, M. G., Rowe, S. P., Subramaniam, R. M., Taneja, S. S., Vargas, H. A. & Ahuja, S., Apr 2020, In : Journal of Nuclear Medicine. 61, 4, p. 552-562 11 p.

    Research output: Contribution to journalArticle

    Open Access